Hairy cell leukemia surgery
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2] Vamsikrishna Gunnam M.B.B.S [3]
Overview
The predominant therapy for hairy cell leukemia is chemotherapy. Surgical management, such as splenectomy, may be required in certain cases.
Surgery
The predominant therapy for hairy cell leukemia is chemotherapy. Surgical management, such as splenectomy, may be required in certain cases.[1]
References
- ↑ Robak T (August 2006). “Current treatment options in hairy cell leukemia and hairy cell leukemia variant”. Cancer Treat. Rev. 32 (5): 365–76. doi:10.1016/j.ctrv.2006.04.010. PMID 16781083.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
